SOP for transporting the COVID-19 Vaccine AstraZeneca from PCN designated sites to end user locations, patients’ homes and within the PCN Grouping.

A standard operating procedure is attached to this page.

You should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations before using this SOP.

The core principles in the SOPs are common and may be adapted for use and sign off in all care settings.

These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in Community Pharmacy settings.



Other handling content for PCNs

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional in England, get in touch with us if you still have questions

Change history

  1. Repaired hyperlinks in AVH7 word document and removed table of Foundry codes
  1. Broken hyperlinks to previous resources removed.
  1. Addition of wording to webpage referring to use within Community Pharmacy settings
  1. Corrected update history to amend numbering error
  1. Updated to reflect Position Statement on vaccination of Care Home residents dated 01/02/2021 and the Mutual Aid policy
  1. Updated to clarify storage of vaccine at GP practice
  2. Rationale for advice on transfer of used vials clarified
  1. Updated to support transfer of used vaccine vial between patients' homes and clarification that the vaccine received at GP practice must be used immediately and not stored
  1. Published